An examination of the effects of stimulant medication on response inhibition: A comparison between children with and without attention deficit hyperactivity disorder

Research in Developmental Disabilities

Volumn 32, Issue 6, 2011, Pages 2797-2804

  Brackenridge, Rachel ^a   McKenzie, Karen ^b   Murray, George C ^c   Quigley, April ^d  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Andrew Lang Unit   (United Kingdom)

^d Psychological Services   (United Kingdom)

Author keywords

ADHD; Animal stroop; Medication; Methylphenidate; Response inhibition

Indexed keywords

METHYLPHENIDATE;

ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRESCHOOL CHILD; RESPONSE INHIBITION; SCHOOL CHILD;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD BEHAVIOR; FEMALE; HUMANS; IMPULSE CONTROL DISORDERS; INHIBITION (PSYCHOLOGY); MALE; METHYLPHENIDATE; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; TREATMENT OUTCOME; WECHSLER SCALES;

EID: 80053645907     PISSN: 08914222     EISSN: 18733379     Source Type: Journal    
DOI: 10.1016/j.ridd.2011.05.027     Document Type: Article

References (51)

1. August G.J., Garfinkel B.D. Comorbidity of ADHD and reading disability among clinic-referred children. Journal of Abnormal Child Psychology 1990, 18:29-45.
2. Barkley R.A. Behavioural inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychological Bulletin 1997, 12(1):65-94.
3. Barkley R.A. Genetics of childhood disorders: XVII. ADHD. Part 1: The executive functions and ADHD. American Academy of Child and Adolescent Psychiatry 2000, 39(8):1064-1068.
4. Booth J.R., Burman D.D., Meyer J.R., Lei Z., Tronmer B.L., Davenport N.D., et al. Larger deficits in brain networks for response inhibition than for visual selective attention in attention deficit hyperactivity disorder. Journal of Child Psychology and Psychiatry 2005, 46(1):94-111.
5. Brown R.T., Levers C.E. Psychotherapy and pharmacotherapy treatment outcome research in pediatric populations. Journal of Clinical Psychology in Medical Settings 1999, 6:63-88.
6. Broyd S.J., Johnstone S.J., Barry R.J., Clarke A.R., McCarthy R., Selikowitz M., et al. The effect of methylphenidate on response inhibition and the event-related potential of children with attention deficit/hyperactivity disorder. International Journal of Psychophysiology 2005, 58(1):47-58.
7. Cohen J. A power primer. Psychological Bulletin 1992, 112(1):155-159.
8. Douglas V.I., Barr R.G., Amin K., O'Neill M.E., Britton B.G. Dosage effects and individual responsivity to methylphenidate in attention deficit disorder. Journal of Child Psychology and Psychiatry 1988, 29:453-475.
9. Everett J., Thomas J., Cote F., Levesque J., Michaud D. Cognitive effects of psychostimulant medication in hyperactive children. Child Psychiatry and Human Development 1991, 22:79-87.
10. Goldman L.S., Genel M., Bezman R.J., Slanetz P.J. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Journal of the American Medical Association 1998, 279:1100-1107.
11. Goodman R. The strengths and difficulties questionnaire: A research note. Journal of Child Psychology, Psychiatry, and Allied Disciplines 1997, 38(5):581-586.
12. Goodman R. Psychometric properties of the strengths and difficulties questionnaire. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40(11):1337-1345.
13. Halperin J.M., Newcorn J.H., Sharma V., Healey J.M., Wolf L.E., Pascualvaca D.M., et al. Inattentive and non-inattentive ADHD children: Do they constitute a unitary group?. Journal of Abnormal Child Psychology 1990, 18:437-449.
14. Hood J., Baird G., Rankin P.M., Isaacs E. Immediate effects of methylphenidate on cognitive attention skills of children with attention-deficit-hyperactivity disorder. Developmental Medicine and Child Neurology 2005, 47(6):408-415.
15. Horrobin S.L., McNair N.A., Kirk I.J., Waldie K.E. Dexamphetamine normalises electrophysiological activity in attention deficit-hyperactivity disorder during the Stroop Task. Neurocase 2007, 13(5):301-310.
16. Houghton S., Douglas G., West J., Whiting K., Wall M., Langsford S., et al. Differential patterns of executive function in children with attention-deficit hyperactivity disorder according to gender and subtype. Journal of Child Neurology 1999, 14:801-805.
17. Johnson M.H. Cortical maturation and the development of visual attention in early Infancy. Brain development and cognition: A reader 1993, 167-193. Blackwell, Oxford. M.H. Johnson (Ed.).
18. Johnston C. The impact of attention-deficit/hyperactivity disorder on social and vocational functioning in adults. Program and Abstracts of NIH Consensus Development Conference on Diagnosis and Treatment of ADHD 1998.
19. Kempton S., Vance A., Maruff P., Luk E., Costin J., Pantelis C. Executive function and attention deficit hyperactivity disorder: Stimulant medication and better executive function performance in children. Psychological Medicine 1999, 29(3):527-538.
20. Kerns K.A., McInerney R.J., Wilde N.J. Time reproduction, working memory and behavioural inhibition in children with ADHD. Child Neuropsychology 2001, 7(1):21-31.
21. Kilian J.B., Hughes L.C.A. A comparison of short forms of the Wechsler Intelligence Scale for Children-Revised in the screening of gifted referrals. Gifted Child Quarterly 1978, 22:111-115.
22. Lawrence Y., Houghton S., Tannock R., Douglas G. ADHD outside the laboratory: Boys' executive function performance on tasks in video game play and on a visit to the zoo. Journal of Abnormal Psychology 2002, 30:447-463.
23. Miller A., Lee S., Raina P., Klasses A., Zupancic J., Olsen L. A review of therapies for attention deficit/hyperactivity disorder 1998, Canadian Coordinating Office for Health Technology Assessment, Ottawa.
24. MTA Cooperative Group Fourteen-month randomized clinical trial of treatment strategies for attention-deficit hyperactivity disorder. Archives of General Psychiatry 1999, 56:1073-1086.
25. National Institute of Clinical Excellence (NICE) Guidance on the use of methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (AD/HD) in childhood 2000, Technology Appraisal Guidance No. 13.
26. Owens J.S., Hoza B. The role of inattention and hyperactivity/impulsivity in the positive illusory bias. Journal of Consulting and Clinical Psychology 2003, 71(4):680-691.
27. Pelham W.E. The effects of psychostimulant drugs on learning and academic achievement in children with attention-deficit disorders and learning disabilities. Psychological and educational perspectives on learning disabilities 1986, 259-295. Academic Press, New York. J.K. Torgesen, B.Y.L. Wong (Eds.).
28. Pelham W.E., Gnagy E.M., Burrows-Maclean L., Williams A., Fabiano G.A., Morrisey S.M., et al. Once-a-day concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings. Pediatrics 2001, 107:e105-e120.
29. Pelham W.E., Wheeler T., Chronis A. Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. Journal of Clinical Child Psychology 1998, 27:190-205.
30. Pennington B.F., Ozonoff S. Executive functions and developmental psychopathology. Journal of Child Psychology and Psychiatry 1996, 37(1):51-87.
31. Quinn P.C., Eimas P.D. Perceptual cues that permit categorical differentiation of animal species by infants. Journal of Experimental Child Psychology 1996, 63:189-211.
32. Rappley M.D. Attention deficit-hyperactivity disorder. New England Journal of Medicine 2005, 352(2):165-172.
33. Rapport M.D., Kelly K.L. Psychostimulant effects on learning and cognitive function: Findings and implications for children with attention deficit hyperactivity disorder. Clinical Psychology Review 1991, 11:61-92.
34. Rubia K., Taylor E., Smith A.B., Oksannen H., Overmeyer S., Newman S. Neuropsychological analyses of impulsiveness in childhood hyperactivity. The British Journal of Psychiatry 2001, 179:138-143.
35. Sattler J.M. Assessment of children 1992, Jerome M. Sattler, San Diego, CA. 3rd ed.
36. Schachar R., Logan G.D. Impulsivity and inhibitory control in normal development and childhood psychopathology. Developmental Psychology 1990, 26(5):710-720.
37. Scheres A., Oosterlaan J., Swanson J., Morein-Zamir S., Meiran N., Schut H., et al. The effect of methylphenidate on three forms of response inhibition in boys with AD/HD. Journal of Abnormal Child Psychology 2003, 31:105-120.
38. Scottish Intercollegiate Guidance Network (SIGN) Attention deficit and hyperkinetic disorders in children and young people 2001, SIGN, Edinburgh.
39. Seidman L.J., Biederman J., Faraone S.V., Weber W., Ouellette C. Toward defining a neuropsychology of attention deficit-hyperactivity disorder: Performance of children and adolescents from a large clinically referred sample. Journal of Consulting & Clinical Psychology 1997, 65(1):150-160.
40. Sonuga-Barke E.J.S., Williams E., Hall M., Saxton T. Hyperactivity and delay aversion III: The effect on cognitive style of imposing delay after errors. Journal of Child Psychology and Psychiatry 1996, 37:189-194.
41. Stroop J.R. Studies of interference in serial verbal reactions. Journal of Experimental Psychology 1935, 18:643-662.
42. Tannock R., Schachar R.J., Carr R.P., Chajczyk D., Logan G.D. Effects of methylphenidate on inhibitory control in hyperactive children. Journal of Abnormal Child Psychology 1989, 17:473-491.
43. Tannock R., Schachar R., Logan G. Methylphenidate and cognitive flexibility: Dissociated dose effects in hyperactive children. Journal of Abnormal Child Psychology 1995, 23:235-266.
44. Taylor E. Issues in the management of hyperkinetic children. Progress in Neurology and Psychiatry 1999, 3(Suppl.):1-19.
45. Taylor E., Chadwick O., Heptinstall E., Danckaerts M. Hyperactivity and conduct problems as risk factors for adolescent development. Journal of the American Academy of Child and Adolescent Psychiatry 1996, 35:1213-1226.
46. van Mourik R., Oosterlaan J., Sergeant J.A. The Stroop revisited: A meta-analysis of interference control in AD/HD. Journal of Child Psychology and Psychiatry 2005, 46(2):150-165.
47. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gerasimov M., Maynord L., et al. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain. Journal of Neuroscience 2001, 21:1-5.
48. Wechsler D. Wechsler Intelligence Scale for Children 1991, The Psychological Corporation, San Antonio, TX. 3rd ed.
49. Weiss M., Murray C. Assessment and management of attention deficit hyperactivity disorder in adults. Canadian Medical Association Journal 2003, 168(6):715-722.
50. Williams B.R., Ponesse J.S., Schachar R.J., Logan G.D., Tannock R. Development of inhibitory control. Developmental Psychology 1999, 35(1):205-213.
51. Wright I., Waterman M., Prescott H., Murdoch-Eaton D. A new Stroop-like measure of inhibitory function development: Typical developmental trends. Journal of Child Psychology and Psychiatry 2003, 44(4):561-575.